American Century Companies’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,164
Closed -$495K 2865
2025
Q3
$495K Buy
24,164
+95
+0.4% +$1.51K ﹤0.01% 2513
2025
Q2
$325K Buy
24,069
+8,286
+52% +$90.6K ﹤0.01% 2644
2025
Q1
$137K Buy
15,783
+1,387
+10% +$8.48K ﹤0.01% 2803
2024
Q4
$70K Sell
14,396
-216
-1% -$1.21K ﹤0.01% 2859
2024
Q3
$113K Sell
14,612
-24,772
-63% -$220K ﹤0.01% 2825
2024
Q2
$394K Sell
39,384
-37,750
-49% -$415K ﹤0.01% 2522
2024
Q1
$937K Buy
77,134
+32,239
+72% +$468K ﹤0.01% 2177
2023
Q4
$642K Buy
+44,895
New +$431K ﹤0.01% 2268
2022
Q3
Sell
-616,159
Closed -$16.9M 2464
2022
Q2
$16.9M Buy
616,159
+27,385
+5% +$811K 0.01% 736
2022
Q1
$22.2M Buy
588,774
+163,729
+39% +$7.25M 0.02% 662
2021
Q4
$26.4M Buy
425,045
+43,131
+11% +$3.27M 0.02% 629
2021
Q3
$32.7M Buy
+381,914
New +$24M 0.02% 563

Other funds holding OPRX

American Century Companies's OPRX Position: Q4 2025 in Review

American Century Companies sold out of OptimizeRx (OPRX) in Q4 2025, closing a stake of 24,164 shares — an estimated $495K sold.

American Century Companies first reported a position in OPRX in Q3 2021 and held it in 12 quarters. The position peaked at $32.7M in Q3 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2025.

  • American Century Companies reported no remaining OptimizeRx position as of Q4 2025 after selling out during the quarter.
  • American Century Companies sold 24,164 OptimizeRx shares in Q4 2025, an estimated $495K.
  • American Century Companies first reported a position in OptimizeRx in Q3 2021 and held it in 12 quarters.
  • American Century Companies's OptimizeRx position peaked at $32.7M in Q3 2021.
  • 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2025.

Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.